Buprenorphine Waiver Training
Additional Fee Session
Saturday, May 8, 2020 - 1:00 - 5:00 PM
COURSE FACULTY
Session Coordinator: Aaron D. Fox, MD, Montefiore Medical Center
Additional Faculty: Tiffany Lu, MD, Montefiore Medical Center
SESSION SUMMARY
This workshop is a buprenorphine “half-and-half” waiver training (4-hours in-person at the conference, followed by 4-hours of online training). This will fulfill the 8-hour training required to apply for a waiver to prescribe buprenorphine for treatment of opioid use disorder. During the workshop, instructors will cover core content, mandated by the federal training requirement, as well as practical resources (connection to mentors, patient and provider materials).
LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:
- List factors important to patient selection for office-based buprenorphine treatment
- Identify the clinically relevant pharmacological characteristics of buprenorphine/methadone/naltrexone
- Describe the resources needed to establish office-based treatment with buprenorphine and other medications for patients with opioid use disorders.
SESSION AGENDA
Core content will include:
1. Overview: Opioid Dependence and Treatment with Buprenorphine/Naloxone
- History of medical practice related to opioids
- DATA 2000 and amendments
- Buprenorphine: Pharmacology, Formulations, Public health issues, Diversion, Maintenance, Dosing, Side effects, Comparison with Methadone
2.
Patient Evaluation
- Taking a history
- DSM V criteria for OUD
- Detecting Substance Use
- Comorbid Psychiatric Disorders
- Considerations for determining appropriateness of office based Buprenorphine Treatment
3. Clinical Uses of Buprenorphine
- Induction
- Stabilization
- Maintenance
- Withdrawal
- Appropriate use of Naltrexone
Registration Fees
All Attendees: $40.00
REGISTER NOW
Registration Fee of $40 includes an afternoon coffee break. Attendees are encouraged to have lunch on their own before the session begins at 1:00 PM.